Dr. Reddy’s Stakes Claim In U.S. OTC Market With Leiner Deal

Dr. Reddy's Laboratories' foothold in the U.S. OTC drug market appears ready for expansion after the firm signed an exclusive 15-year OTC product development and marketing agreement with Leiner Health Products

More from Archive

More from Pink Sheet